Credit Suisse Group reissued their buy rating on shares of RELX PLC (REL.L) (LON:REL) in a research note released on Friday, Analyst Ratings Network reports. Credit Suisse Group currently has a GBX 1,956 ($25.56) price target on the stock.
Several other equities analysts have also weighed in on the stock. Barclays set a GBX 2,005 ($26.20) price objective on shares of RELX PLC (REL.L) and gave the company a buy rating in a research report on Thursday, October 22nd. JPMorgan Chase & Co. set a GBX 2,000 ($26.13) price target on shares of RELX PLC (REL.L) and gave the stock a buy rating in a research report on Thursday, October 8th. BNP Paribas cut RELX PLC (REL.L) to an underperform rating and dropped their price target for the company from GBX 1,900 ($24.82) to GBX 1,650 ($21.56) in a report on Tuesday, June 30th. Citigroup reissued a buy rating on shares of RELX PLC (REL.L) in a research note on Thursday, July 16th. Finally, Berenberg Bank cut their target price on RELX PLC (REL.L) from GBX 2,080 ($27.18) to GBX 1,800 ($23.52) and set a hold rating on the stock in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company. The stock has an average rating of Hold and an average price target of GBX 1,902.90 ($24.86).
Shares of REL stock opened at GBX 1,607 ($21.00) on Friday. The stock has a 50-day simple moving average of GBX 1,724.45 and a 200 day simple moving average of GBX 1,779.37. The stock has a market capitalization of $33.75 billion and a P/E ratio of 24.50. RELX PLC has a fifty-two week low of GBX 1,382.86 ($18.07) and a fifty-two week high of GBX 2,109 ($27.55). The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 373.30.
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare.
Featured Article: Why are gap-down stocks important?
Receive News & Ratings for RELX PLC (REL.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RELX PLC (REL.L) and related companies with MarketBeat.com's FREE daily email newsletter.